Cited by 664Sleep and related disordersHealth Systems, Economic Evaluations, Quality of LifeObstructive Sleep Apnea Research

The Economic Burden of Insomnia: Direct and Indirect Costs for Individuals with Insomnia Syndrome, Insomnia Symptoms, and Good Sleepers

Open access
Meagan Daley, Charles M. Morin, Mélanie LeBlanc, Jean‐Pierre Grégoire, Josée Savard·2009·Sleep

Abstract

BACKGROUND AND PURPOSE: Insomnia is a highly prevalent problem that is associated with increased use of health care services and products, as well as functional impairments. This study estimated from a societal perspective the direct and indirect costs of insomnia. PARTICIPANTS AND METHODS: A randomly selected sample of 948 adults (mean age = 43.7 years old; 60% female) from the province of Quebec, Canada completed questionnaires on sleep, health, use of health-care services and products, accidents, work absences, and reduced productivity. Data were also obtained from the Quebec government administered health insurance board regarding consultations and hospitalizations. Participants were categorized as having insomnia syndrome, insomnia symptoms or as being good sleepers using a standard algorithm. Frequencies of target cost variables were obtained and multiplied by unit costs to generate estimates of total costs for the adult population of the province of Quebec. RESULTS: The total annual cost of insomnia in the province of Quebec was estimated at $6.6 billion (Cdn$). This includes direct costs associated with insomnia-motivated health-care consultations ($191.2 million) and transportation for these consultations ($36.6 million), prescription medications ($16.5 million), over the-counter products ($1.8 million) and alcohol used as a sleep aid ($339.8 million). Annual indirect costs associated with insomnia-related absenteeism were estimated at $970.6 million, with insomnia-related productivity losses estimated at $5.0 billion. The average annual per-person costs (direct and indirect combined) were $5,010 for individuals with insomnia syndrome, $1431 for individuals presenting with symptoms, and $421 for good sleepers. CONCLUSIONS: This study suggests that the economic burden of insomnia is very high, with the largest proportion of all expenses (76%) attributable to insomnia-related work absences and reduced productivity. As the economic burden of untreated insomnia is much higher than that of treating insomnia, future clinical trials should evaluate the cost-benefits, cost-utility, and cost-effectiveness of insomnia therapies.

Integrity signals

Registry

Crossref · 10.5665/sleep/32.1.55

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Daley, M., Morin, C. M., LeBlanc, M., Grégoire, J., & Savard, J.
Affiliations
  • Université Laval (CA)
  • Hôpital du Saint-Sacrement (CA)
Corresponding author
Charles M. Morin
Venue
Sleep
Published
2009-01-01
Volume
32
Issue
1
Pages
55-64
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W86291341
Cited by
664
References
6
Citations by year
2026: 6 · 2025: 32 · 2024: 46 · 2023: 42 · 2022: 48 · 2021: 63 · 2020: 41 · 2019: 50 · 2018: 45 · 2017: 41 · 2016: 34 · 2015: 39 · 2014: 46 · 2013: 42 · 2012: 32
FWCI
37.24
Type
journal article
Language
en
Open access
Locations
  • SLEEP (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
Funders
  • Novartis
  • Sanofi
  • Merck Canada
  • Novartis Pharma
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
Keywords
insomnia, economic burden, direct costs, indirect costs, productivity loss, absenteeism, health care utilization, prescription drugs, social costs, Quebec
MeSH terms
Absenteeism, Accidents, Adolescent, Adult, Aged, Aged, 80 and over, Alcoholic Beverages, Cost-Benefit Analysis, Efficiency, Female, Health Surveys, Hospitalization, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Quebec, Surveys and Questionnaires, Referral and Consultation, Drug Costs, Health Care Costs, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review